Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes detecting four infections simultaneously
Test provides a critically important tool as people return to regular... Diagnostics, FDA Abbott, Alinity m, Hepatitis C, Hepatitis B, HIV (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 4, 2022 Category: Pharmaceuticals Source Type: news
Steven Tyler beat hepatitis C with discontinued interferon treatment - ‘about killed me'
IN the past Aerosmith singer Steven Tyler underwent nearly a year of chemotherapy to treat his hepatitis. (Source: Daily Express - Health)
Source: Daily Express - Health - April 25, 2022 Category: Consumer Health News Source Type: news
IHS: Ending the HIV/HCV Epidemics in Indian Country: A Program for American Indian/Alaska Native Tribes and Urban Indian Communities
The Indian Health Service (IHS) is accepting applications for a cooperative agreement for the Ending the Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Epidemics in Indian Country (ETHIC) program. The purpose of this program is to support communities in reducing new HIV infections and relevant co-morbidities and reducing HIV, sexually transmitted infections, and HCV-related health disparities among American Indian/Alaska Native people. Applications are due by June 17, 2022. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - April 18, 2022 Category: Rural Health Source Type: news
Decade after hepatitis outbreak, medical registry might end
A decade after New Hampshire stopped a traveling medical technician who had been stealing drugs and infecting patients with hepatitis C, the Legislature might eliminate a registration system aimed at preventing similar misconduct (Source: ABC News: Health)
Source: ABC News: Health - April 9, 2022 Category: Consumer Health News Tags: Health Source Type: news
Prevalence of hepatitis C in sexual assault survivors presenting to a SANE clinic: a descriptive analysis - Ward E, Carlisle N, Williams E, Heath SL, Meloun K, Walter LA.
While previous epidemiologic research has demonstrated that sexual assault survivors (SAS) may be at disproportionate risk for exposure to Hepatitis C (HCV), HCV screening in SAS is not addressed in current post-sexual assault testing recommendations. We s... (Source: SafetyLit)
Source: SafetyLit - April 4, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
U.S. FDA Approves CARVYKTI ™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
HORSHAM, Pa., February 28, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel) for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.1 The approval is based on data from the pivotal CARTITUDE-1 study, which included patients who had received a median of six prior treatment regimens (range, 3-18), and had previously rec...
Source: Johnson and Johnson - March 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Health Care Usage Down With DAA Therapy for Chronic Hep C
MONDAY, Feb. 28, 2022 -- Among patients with chronic hepatitis C virus (HCV) infection, those who have sustained virological response (SVR) to direct-acting antiviral (DAA) therapy have reductions in measures of health care utilization compared with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2022 Category: Pharmaceuticals Source Type: news
FDA-approved drugs for diabetes, hepatitis C, HIV may help treat COVID-19, study finds
Drugs used to treat diseases such as Type 2 diabetes, hepatitis C and HIV may stop the Delta variant of COVID-19 from replicating in, or infecting and spreading in, human cells. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 25, 2022 Category: Consumer Health News Source Type: news
Repurposing FDA-approved drugs may help combat COVID-19
Several FDA-approved drugs - including for type 2 diabetes, hepatitis C and HIV - significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. Specifically, the team found that these drugs inhibit certain viral enzymes, called proteases, that are essential for SARS-CoV-2 replication in infected human cells. (Source: World Pharma News)
Source: World Pharma News - February 25, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Hepatitis C Virus Positivity Linked to Schizophrenia Development
Incidence of overall mortality was also highest for untreated patients with hepatitis C virus (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - February 24, 2022 Category: Psychiatry Tags: Family Medicine, Gastroenterology, Infections, Internal Medicine, Psychiatry, Journal, Source Type: news
Hepatitis C Virus Positivity Linked to Schizophrenia Development
THURSDAY, Feb. 24, 2022 -- Hepatitis C virus (HCV) positivity is associated with development of schizophrenia, according to a study recently published in the Journal of Psychiatry& Neuroscience.
Jur-Shan Cheng, Ph.D., from Chang Gung... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 24, 2022 Category: Pharmaceuticals Source Type: news
Dangerous Medicine: The Story Behind Human Experiments with Hepatitis – review
Sydney Halpern ’s account of postwar US research that deliberately infected hundreds with the disease is shocking – and important for the Covid eraFor three decades after the second world war, US scientists and doctors carried out a research programme of striking ambition – and breathtaking moral negligence. They deliberately infected more than 1,000 people, including at least 100 children, with hepatitis, an illness that can trigger chronic liver disease and cancer.Very few of those subjected to this experimentation had much idea of what was being inflicted upon them. Many were poor and uneducated and came from pris...
Source: Guardian Unlimited Science - February 20, 2022 Category: Science Authors: Robin McKie Tags: Science and nature books Culture Hepatitis B Hepatitis C Medical research Source Type: news
Pandemic Era Tests May Speed Hepatitis-C Detection
A wave of diagnostics ushered in by Covid could help revive flagging efforts to eliminate the disease. (Source: NYT Health)
Source: NYT Health - February 4, 2022 Category: Consumer Health News Authors: Ted Alcorn Tags: Tests (Medical) Hepatitis Coronavirus (2019-nCoV) Regulation and Deregulation of Industry Food and Drug Administration Source Type: news
Hepatitis C is a growing threat to moms and babies. But screening is inadequate.
Obstetricians already routinely screen women for hepatitis B, HIV and syphilis, but not always for hepatitis C, even though the disease is often more prevalent. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - January 29, 2022 Category: Consumer Health News Authors: Christine Nguyen Source Type: news
International research collaboration to investigate eliminating hepatitis C in Ethiopia
An international research team will lead elimination efforts of Hepatitis C in Ethiopia - one of the worst affected African countries of the disease - thanks to funding of £ 2.2 million by the National Institute for Health Research (NIHR). (Source: University of Bristol news)
Source: University of Bristol news - January 26, 2022 Category: Universities & Medical Training Tags: Announcements, Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Institutes, Institutes, Bristol Population Health Science Institute, Institutes, Elizabeth Blackwell; Press Release Source Type: news
